Literature DB >> 28612770

National policies for safety of medicines in the Asia Pacific region.

Socorro Escalante1, John McEwen2.   

Abstract

National medicines policies can aid the safe use of medicines by ensuring availability of quality products, appropriate information for prescribers and consumers, strengthening the national medicines regulatory capacity and improving access to expert advice and authoritative laboratory testing. We report the findings of a workshop on medicines safety, which focused on the Asia Pacific region. Participants noted that external support is needed for resource-poor countries and that national medicines policies should include surveillance on problems with medicines, rather than the more limited monitoring of adverse drug reactions. The latter approach may be the only sensible option in countries in the Asia Pacific with very small populations.

Entities:  

Year:  2013        PMID: 28612770     DOI: 10.4103/2224-3151.122947

Source DB:  PubMed          Journal:  WHO South East Asia J Public Health        ISSN: 2224-3151


  1 in total

1.  Pacific Island Pharmacovigilance: The Need for a Different Approach.

Authors:  John McEwen; Lasse S Vestergaard; Amanda L C Sanburg
Journal:  Drug Saf       Date:  2016-10       Impact factor: 5.606

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.